1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Non-Invasive Cancer Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Non-Invasive Cancer Diagnostics Market, by Type
8.1.1. Lung Cancer
8.1.1.1. Market Revenue and Forecast
8.1.2. Breast Cancer
8.1.2.1. Market Revenue and Forecast
8.1.3. Solid Tumors
8.1.3.1. Market Revenue and Forecast
8.1.4. Blood Cancer
8.1.4.1. Market Revenue and Forecast
8.1.5. Ovarian Cancer
8.1.5.1. Market Revenue and Forecast
8.1.6. Colorectal Cancer
8.1.6.1. Market Revenue and Forecast
8.1.7. Other
8.1.7.1. Market Revenue and Forecast
9.1. Non-Invasive Cancer Diagnostics Market, by Product Type
9.1.1. Immunochemistry
9.1.1.1. Market Revenue and Forecast
9.1.2. Clinical Microbiology
9.1.2.1. Market Revenue and Forecast
9.1.3. Point of Care Test (POCT)
9.1.3.1. Market Revenue and Forecast
9.1.4. Hematology
9.1.4.1. Market Revenue and Forecast
9.1.5. Hemostasis
9.1.5.1. Market Revenue and Forecast
10.1. Non-Invasive Cancer Diagnostics Market, by Test Type
10.1.1. Urine Test
10.1.1.1. Market Revenue and Forecast
10.1.2. Imaging Test
10.1.2.1. Market Revenue and Forecast
10.1.3. Computerized Tomography
10.1.3.1. Market Revenue and Forecast
10.1.4. Magnetic Resonance Imaging
10.1.4.1. Market Revenue and Forecast
10.1.5. Nuclear Medicine Scans
10.1.5.1. Market Revenue and Forecast
10.1.6. X-ray/Mammography
10.1.6.1. Market Revenue and Forecast
10.1.7. Ultrasound
10.1.7.1. Market Revenue and Forecast
10.1.8. Spectroscopy
10.1.8.1. Market Revenue and Forecast
11.1. Non-Invasive Cancer Diagnostics Market, by Application
11.1.1. Blood
11.1.1.1. Market Revenue and Forecast
11.1.2. Urine
11.1.2.1. Market Revenue and Forecast
11.1.3. Saliva
11.1.3.1. Market Revenue and Forecast
cast
12.1. Non-Invasive Cancer Diagnostics Market, by End Users
12.1.1. Hospital and Clinics
12.1.1.1. Market Revenue and Forecast
12.1.2. Diagnostic Centers
12.1.2.1. Market Revenue and Forecast
12.1.3. Ambulatory care
12.1.3.1. Market Revenue and Forecast
12.1.4. Others
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type
13.1.2. Market Revenue and Forecast, by Product Type
13.1.3. Market Revenue and Forecast, by Test Type
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End Users
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type
13.1.6.2. Market Revenue and Forecast, by Product Type
13.1.6.3. Market Revenue and Forecast, by Test Type
13.1.6.4. Market Revenue and Forecast, by Application
13.1.6.5. Market Revenue and Forecast, by End Users
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Type
13.1.7.2. Market Revenue and Forecast, by Product Type
13.1.7.3. Market Revenue and Forecast, by Test Type
13.1.7.4. Market Revenue and Forecast, by Application
13.1.7.5. Market Revenue and Forecast, by End Users
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type
13.2.2. Market Revenue and Forecast, by Product Type
13.2.3. Market Revenue and Forecast, by Test Type
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End Users
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type
13.2.6.2. Market Revenue and Forecast, by Product Type
13.2.6.3. Market Revenue and Forecast, by Test Type
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End Users
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type
13.2.9.2. Market Revenue and Forecast, by Product Type
13.2.9.3. Market Revenue and Forecast, by Test Type
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End Users
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type
13.2.12.2. Market Revenue and Forecast, by Product Type
13.2.12.3. Market Revenue and Forecast, by Test Type
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End Users
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type
13.2.14.2. Market Revenue and Forecast, by Product Type
13.2.14.3. Market Revenue and Forecast, by Test Type
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End Users
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type
13.3.2. Market Revenue and Forecast, by Product Type
13.3.3. Market Revenue and Forecast, by Test Type
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End Users
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type
13.3.6.2. Market Revenue and Forecast, by Product Type
13.3.6.3. Market Revenue and Forecast, by Test Type
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End Users
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type
13.3.8.2. Market Revenue and Forecast, by Product Type
13.3.8.3. Market Revenue and Forecast, by Test Type
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End Users
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type
13.3.10.2. Market Revenue and Forecast, by Product Type
13.3.10.3. Market Revenue and Forecast, by Test Type
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End Users
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type
13.3.11.2. Market Revenue and Forecast, by Product Type
13.3.11.3. Market Revenue and Forecast, by Test Type
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End Users
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type
13.4.2. Market Revenue and Forecast, by Product Type
13.4.3. Market Revenue and Forecast, by Test Type
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End Users
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type
13.4.6.2. Market Revenue and Forecast, by Product Type
13.4.6.3. Market Revenue and Forecast, by Test Type
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End Users
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type
13.4.8.2. Market Revenue and Forecast, by Product Type
13.4.8.3. Market Revenue and Forecast, by Test Type
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End Users
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type
13.4.10.2. Market Revenue and Forecast, by Product Type
13.4.10.3. Market Revenue and Forecast, by Test Type
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End Users
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type
13.4.11.2. Market Revenue and Forecast, by Product Type
13.4.11.3. Market Revenue and Forecast, by Test Type
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End Users
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type
13.5.2. Market Revenue and Forecast, by Product Type
13.5.3. Market Revenue and Forecast, by Test Type
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End Users
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type
13.5.6.2. Market Revenue and Forecast, by Product Type
13.5.6.3. Market Revenue and Forecast, by Test Type
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End Users
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type
13.5.8.2. Market Revenue and Forecast, by Product Type
13.5.8.3. Market Revenue and Forecast, by Test Type
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End Users
14.1. Abbott
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Illumina, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. QIAGEN
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. F. Hoffmann-La Roche Ltd
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Agilent Technologies, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Quest Diagnostics Incorporated.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Merck KGaA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Hologic, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. BD.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
